GT Biopharma (OXIA.F) Q4 2024 Earnings

14NovConfirmed
Q2 2024
Q3 2024
Q4 2024
-2.56
-2.19
-1.82
-1.45

Details

Expected EPS
-2.564082
Actual EPS
-1.4529798
Surprise EPS
1.11
Surprise Percent
+43.33%

Description

GT Biopharma (OXIA.F) has reported earnings of -1.4529798 per share for Q4 2024.

0 Comments

Share your thoughts